|
METTL9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.12710002126471E-09 |
| Normal-vs-Stage2 |
2.583700E-03 |
| Normal-vs-Stage3 |
2.256300E-03 |
| Normal-vs-Stage4 |
1.801900E-02 |
| Stage1-vs-Stage2 |
6.732800E-01 |
| Stage1-vs-Stage3 |
2.874400E-01 |
| Stage1-vs-Stage4 |
9.360800E-01 |
| Stage2-vs-Stage3 |
5.561600E-01 |
| Stage2-vs-Stage4 |
8.067400E-01 |
| Stage3-vs-Stage4 |
4.252200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6251444634463E-12 |
| Normal-vs-AfricanAmerican |
2.208300E-04 |
| Normal-vs-Asian |
3.152200E-01 |
| Caucasian-vs-AfricanAmerican |
1.181560E-01 |
| Caucasian-vs-Asian |
7.627200E-01 |
| AfricanAmerican-vs-Asian |
8.012200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62925228863742E-12 |
| Normal-vs-Female |
3.20590000002507E-06 |
| Male-vs-Female |
9.535000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.664700E-03 |
| Normal-vs-Extreme_Weight |
2.33289999995723E-06 |
| Normal-vs-Obese |
7.2141999996056E-07 |
| Normal-vs-Extreme_Obese |
9.060000E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.328800E-01 |
| Normal_Weight-vs-Obese |
1.514230E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.400600E-01 |
| Extreme_Weight-vs-Obese |
2.027400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.420200E-01 |
| Obese-vs-Extreme_Obese |
8.656400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.696500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.04459996208561E-10 |
| Normal-vs-Age(61-80Yrs) |
5.65160029886158E-10 |
| Normal-vs-Age(81-100Yrs) |
1.814270E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.299800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.246400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.605800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.361200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.451200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.384400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64313007644523E-12 |
| Normal-VS-Type2 PRCC |
1.20329999997448E-06 |
| Normal-VS-KIRP CIMP |
2.930800E-01 |
| Normal-VS-Unclassified PRCC |
3.378200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.035200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.574030E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.377600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.913220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.429800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.851390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.987050E-04 |
| Normal-vs-N1 |
5.699600E-03 |
| Normal-vs-N2 |
2.672800E-01 |
| N0-vs-N1 |
7.704800E-01 |
| N0-vs-N2 |
8.354000E-01 |
| N1-vs-N2 |
7.417200E-01 |
|
|
